SMS service for awareness on cheaper drugs:
Sep 1, 2012, 12.59PM IST, The writer has posted comments on this article PTI
NEW DELHI: The Department of Pharmaceuticals in the Ministry of Chemicals and Fertilisers is planning to launch a SMS service providing information about affordable alternatives to medicines prescribed by doctors.The Short Message Service (SMS) facility could help poor patients find cheaper alternatives to medicines prescribed by doctors.
The Ministry of Health and Family Welfare has sought that all 348 drugs listed in the National List of Essential Medicines, 2011 should be brought within the purview of the Drug Price Control Order (DPCO) so that there should be minimum impact on the expenses of consumer.Link : http://timesofindia.indiatimes.com/tech/enterprise-it/services-apps/SMS-service-for-awareness-on-cheaper-drugs-in-the-offing/articleshow/16125680.cms
|NPPA has initiated a process to end the freedom enjoyed by
drug makers to fix the retail price of their imported medicines
Pricing of imported drugs under regulatory scanner:
6 Sep, 2012,07.38AM IST, The writer has posted comments on this article Khomba SinghKhomba Singh,ET Bureau
India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.The National Pharmaceutical Pricing Authority has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
"There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug)," Singh said. "We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price."
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. "We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage," said Rakesh Bamzai, president (marketing), at Biocon.
Link : http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274253.cms
HC notice to Centre on generic drugs
Sep 11, 2012, 07.04 AM IST, The writer has posted comments on this articleTNN
The petitioner has sought direction to pharmaceutical department of ministry of chemicals and fertilisers as well as National Pharmaceutical Pricing Authority to take effective steps to control prices of generic medicines so that they could come within reach of the common man.
The ministry of corporate affairs conducted a study on non-scheduled drugs manufactured and marketed by leading pharmaceutical companies in the country and found that the profit margins were exorbitantly high.
The ministry wrote on June 12, 2012 to the ministry of health and family welfare as well as ministry of chemical and fertilisers for taking action in the matter but till date nothing has been done, said the petition.
Link : http://timesofindia.indiatimes.com/city/lucknow/HC-notice-to-Centre-on-generic-drugs/articleshow/16346263.cms
Pharma GoM finalises pricing policy, to cover 348 drugsThu, Sep 27, 2012 at 18:45
A ministers panel, headed by Agriculture Minister Sharad Pawar, finalised the pharma pricing policy under which 348 essential drugs will come under price control of the government.
The Group of Ministers (GoM) will be sending their recommendations to the Cabinet for approval to bring drugs in National List of Essential Medicines (NLEM), that have a total sales of around Rs 29,000 crore, which is about 60 percent of the domestic market, under control.
At present, the government through the National Pharmaceutical Pricing Authority (NPPA), controls prices of 74 bulk drugs and their formulations.
Link : http://www.moneycontrol.com/news/business/pharma-gom-finalises-pricing-policy-to-cover-348-drugs_762652.html#toptag
Reference News Link